Rascol A, Maurel H, David J, Layani M (1974). „[Preliminary clinical results of a new non tricyclic antidepressive drug: oxaflozane]”.Thérapie (на језику: French).29 (1): 95—9.PMID4603757.CS1 одржавање: Непрепознат језик (веза)
Hache J, Duchene-Marullaz P, Streichenberger G (1974). „[Pharmacological profile of a new non tricyclic antidepressant: oxaflozane (1,766 Cerm)]”.Thérapie (на језику: French).29 (1): 81—93.PMID4849381.CS1 одржавање: Непрепознат језик (веза)
Constantin M, Pognat JF (1979). „Comparative study of oxaflozane urinary metabolism in man, the dog and the rat. Identification of the principal metabolites”.Arzneimittel-Forschung.29 (1): 109—14.PMID582104.
Bertolino A, palermo M, Porro V (1985). „Oxaflozane, a new nontricyclic antidepressant in the treatment of anxiety-depressions syndromes.”.Acta Ther (11): 209—218.
Aguglia E (1986). „On the therapetic value of axaflozane: Its application in the treatment of emotional disturbances of the anxious-depressive type accompanied by somatic manifestations.”.Acta Ther (12): 259—267.